|
Mechanismglucokinase activators |
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
A Phase II, Randomised, Double-blind, Placebo-controlled Clinical Trial to Assess the Safety and Efficacy of AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19
The ARCADIA Trial is a randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with either Type 1 or Type 2 diabetes, hospitalised with COVID-19.
100 Clinical Results associated with St George Street Capital Ltd.
0 Patents (Medical) associated with St George Street Capital Ltd.
100 Deals associated with St George Street Capital Ltd.
100 Translational Medicine associated with St George Street Capital Ltd.